| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/06/1997 | CA2226879A1 Transferrin glycans composition for the induction of immune tolerance |
| 02/06/1997 | CA2226843A1 Treatment of acute leukemia with interleukin-10 |
| 02/06/1997 | CA2226580A1 Method of treating epilepsy with brain derived neurotrophic factor |
| 02/06/1997 | CA2226523A1 A stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calcium ions |
| 02/06/1997 | CA2226414A1 Phosphorous-containing cysteine and serine protease inhibitors |
| 02/06/1997 | CA2224289A1 New protein hmw human mp52s |
| 02/06/1997 | CA2223914A1 Compositions and methods for catalyzing hydrolysis of hiv gp120 |
| 02/06/1997 | CA2223489A1 Method for treating cancer using ahpn |
| 02/06/1997 | CA2200295A1 Enterogenin pharmaceutical form |
| 02/06/1997 | CA2196802A1 Metal-containing ribonucleotide polypeptides |
| 02/05/1997 | EP0757249A1 Method of determining the suppressor cell component of the immune status of an individual and means for carrying out the same |
| 02/05/1997 | EP0757099A2 CTLA4 mutant molecules and uses thereof |
| 02/05/1997 | EP0757058A1 Cyclic peptide anti-fungal agents |
| 02/05/1997 | EP0757057A2 Process for crystallisation of macromolecules |
| 02/05/1997 | EP0757049A1 Camptothecin derivatives |
| 02/05/1997 | EP0756872A1 Collagenase for inducing cervical ripening |
| 02/05/1997 | EP0756871A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 02/05/1997 | EP0756862A1 Use of bradykinine antagonist in a cosmetic, pharmaceutical or dermatological composition and the composition obtained |
| 02/05/1997 | EP0756827A2 Composition for nutrition |
| 02/05/1997 | EP0756638A1 Method and means for detecting and treating disorders in the blood coagulation cascade |
| 02/05/1997 | EP0756636A1 Chondroitinases i and ii, methods of preparation, and use thereof |
| 02/05/1997 | EP0756630A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
| 02/05/1997 | EP0756629A1 Pharmaceutical formulations for treating japanese cedar pollen allergy |
| 02/05/1997 | EP0756628A1 Morphogenic protein-specific cell surface receptors and uses therefor |
| 02/05/1997 | EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
| 02/05/1997 | EP0756625A1 Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups |
| 02/05/1997 | EP0756605A1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
| 02/05/1997 | EP0756604A1 Melanoma antigens |
| 02/05/1997 | EP0756603A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells |
| 02/05/1997 | EP0756602A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines |
| 02/05/1997 | EP0756492A1 Use of g-csf to reduce acute rejection |
| 02/05/1997 | EP0756491A1 Use of brain natriuretic peptides (bnp), phosphorylated urodilatine, phosphorylated cdd/anp and combinations thereof |
| 02/05/1997 | EP0756490A1 Human bone stimulating factor |
| 02/05/1997 | EP0756489A1 Cyclosporin containing composition and process for the preparation thereof |
| 02/05/1997 | EP0756488A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment |
| 02/05/1997 | EP0756487A1 Method for implanting encapsulated cells in a host |
| 02/05/1997 | EP0756449A1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides |
| 02/05/1997 | EP0652895A4 Compounds which inhibit hiv replication. |
| 02/05/1997 | EP0616642B1 New thrombin-inhibiting proteins from terrestrial leeches |
| 02/05/1997 | EP0579830B1 Therapeutic agent for corneal lesion |
| 02/05/1997 | EP0573499B1 Process for the phosphorylation of insulin and product produced thereby |
| 02/05/1997 | CN1142247A Extracorporeal ceel culture and transplantation kits |
| 02/05/1997 | CN1142231A Abundant extracellular products and methods for production and use of same |
| 02/05/1997 | CN1142230A Antibiotic stalobacins |
| 02/05/1997 | CN1142228A Novel amino acid derivatives, method of producing same and pharmaceutical compositions containing these compounds |
| 02/05/1997 | CN1142189A Platelet-special chimeric immunoglobulin and methods of use thereof |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1142186A Use of IL-10 to stimulate peripheral blood mononuclear cell cytolytic activity |
| 02/05/1997 | CN1142184A Antiarrhythmic benzodiazepines |
| 02/05/1997 | CN1141809A Method for treatment of undissolved thrombus acute myocardinal infraction by using hirudin and acetylsalicylic acid |
| 02/05/1997 | CN1141808A Interferon solution |
| 02/05/1997 | CN1033976C Preparation of polypeptides used as blockers of calcium channels |
| 02/04/1997 | US5599918 Nucleic acids encoding trophinin and trophinin-assisting proteins |
| 02/04/1997 | US5599915 Inhibit selectin-mediated cellular adhesion |
| 02/04/1997 | US5599914 Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
| 02/04/1997 | US5599912 Compounds and methods for suppressing an immune response to sulfomethoxozale containing substances |
| 02/04/1997 | US5599909 Process for reactivating purified membrane proteins |
| 02/04/1997 | US5599908 Method for constructing a hybrid reagent for delivering a bioactive molecule to a cellular target |
| 02/04/1997 | US5599907 Production and use of multimeric hemoglobins |
| 02/04/1997 | US5599905 Interleukin-4 receptors |
| 02/04/1997 | US5599903 Glutathione analogs and paralog panels comprising glutathione mimics |
| 02/04/1997 | US5599902 Cancer inhibitory peptides |
| 02/04/1997 | US5599816 Bactericide |
| 02/04/1997 | US5599795 Method for treatment of idiopathic inflammatory bowel disease (IIBD) |
| 02/04/1997 | US5599793 Anticoagulants |
| 02/04/1997 | US5599792 Bone-stimulating, non-vasoactive parathyroid hormone variants |
| 02/04/1997 | US5599791 Bactericide active against gramnegative and grampositive bacteria |
| 02/04/1997 | US5599790 Fibrinogen γ chain polypeptide and compositions thereof |
| 02/04/1997 | US5599789 Method for the treatment of tumours and sarcomas |
| 02/04/1997 | US5599788 Wound healing agents; dermal fibroplast adhesion promoter |
| 02/04/1997 | US5599712 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 02/04/1997 | US5599708 Stimulate formation of osteoclast bone cells; treatment of bone marrow disorders |
| 02/04/1997 | US5599706 Ribozymes targeted to apo(a) mRNA |
| 02/04/1997 | US5599705 In vitro method for producing differentiated universally compatible mature human blood cells |
| 02/04/1997 | US5599693 Culture product |
| 02/04/1997 | US5599692 Antigenic polypeptides of Taenia ovis |
| 02/04/1997 | US5599686 Oligopeptide comprising sequence of amino acids recognized and selectively proteolytically cleaved by free prostate specific antigen |
| 02/04/1997 | US5599680 Diagnostic applications of mouse ascites golgi (MAG) manipulation |
| 02/04/1997 | US5599679 A polypeptide for immuno-competing binding; immunoassay diagnosing bone disorder |
| 02/04/1997 | US5599678 Antibodies which react with fibrinogen fragments E1, E2 and E3 and methods of their use |
| 02/04/1997 | US5599676 Method for isolating a novel receptor for α4 integrins |
| 02/04/1997 | US5599673 Long QT syndrome genes |
| 02/04/1997 | US5599665 Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection |
| 02/04/1997 | US5599560 Method of treating depression using neurotrophins |
| 02/04/1997 | US5599559 Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it |
| 02/04/1997 | US5599539 Administering avian antitoxin |
| 02/04/1997 | US5599536 Method for suppressing the acute phase response in a patient receiving IL-6 therapy |
| 02/04/1997 | US5599323 Syringe system |
| 02/04/1997 | CA2182635A1 Process for the crystallization of macromolecules |
| 02/04/1997 | CA2128199C Stable solid pharmaceutical compositions containing enalapril maleate |
| 02/04/1997 | CA2071425C Prophylactic/therapeutic composition for disseminated intravascular coagulation, or chronic respiratory tract infectious disease |
| 01/30/1997 | WO1997003360A1 HELICOBACTER VACCINE ANTIGEN RECOGNIZED BY A PROTECTIVE MONOCLONAL ANTIBODY (IgG 50) |
| 01/30/1997 | WO1997003358A1 Method of identifying inhibitors of the jak-stat signal transduction pathway |
| 01/30/1997 | WO1997003211A1 Antisense inhibition of hepatitis b virus replication |
| 01/30/1997 | WO1997003199A1 Herpes simplex virus glycoprotein d variants |
| 01/30/1997 | WO1997003198A2 Nucleotide and amino acid sequence and uses thereof |
| 01/30/1997 | WO1997003196A1 CLONING, TISSUE DISTRIBUTION, AND FUNCTIONAL ANALYSIS OF Na+/H+ EXCHANGER ISOFORM, NHE3 |
| 01/30/1997 | WO1997003195A1 Novel factor viii:c polypeptide analogs with altered protease sites |
| 01/30/1997 | WO1997003194A1 Lysine 1689 factor viii:c polypeptide analogs |
| 01/30/1997 | WO1997003193A1 Novel factor viii:c polypeptide analogs with altered metal-binding properties |